CCM
ELV icon

Coldstream Capital Management’s Elevance Health ELV Stock Holding History

Coldstream Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Buy
6,074
+1,017
+20% +$377K 0.03% 268
2026
Q1 		$1.48M Sell
5,057
-826
-14% -$271K 0.02% 368
2025
Q4 		$2.06M Sell
5,883
-91
-2% -$30.8K 0.03% 279
2025
Q3 		$1.93M Buy
5,974
+467
+8% +$145K 0.03% 310
2025
Q2 		$2.14M Buy
5,507
+714
+15% +$287K 0.04% 266
2025
Q1 		$2.08M Buy
4,793
+876
+22% +$352K 0.04% 239
2024
Q4 		$1.44M Sell
3,917
-269
-6% -$113K 0.03% 305
2024
Q3 		$2.13M Buy
4,186
+490
+13% +$262K 0.05% 224
2024
Q2 		$2M Buy
3,696
+53
+1% +$28K 0.05% 204
2024
Q1 		$1.89M Buy
3,643
+172
+5% +$85.5K 0.05% 210
2023
Q4 		$1.64M Buy
3,471
+23
+0.7% +$10.6K 0.05% 211
2023
Q3 		$1.5M Sell
3,448
-106
-3% -$48.1K 0.05% 212
2023
Q2 		$1.58M Sell
3,554
-177
-5% -$81.7K 0.05% 210
2023
Q1 		$1.72M Sell
3,731
-116
-3% -$55.2K 0.06% 200
2022
Q4 		$1.97M Buy
+3,847
New +$1.95M 0.07% 173
2022
Q2 		$1.73M Buy
3,583
+567
+19% +$281K 0.07% 158
2022
Q1 		$1.48M Sell
3,016
-195
-6% -$89.1K 0.05% 197
2021
Q4 		$1.49M Buy
3,211
+1,984
+162% +$835K 0.05% 203
2021
Q3 		$330K Sell
1,227
-231
-16% -$87.8K 0.02% 299
2021
Q2 		$557K Buy
1,458
+32
+2% +$12.2K 0.02% 260
2021
Q1 		$512K Buy
1,426
+129
+10% +$41.5K 0.03% 220
2020
Q4 		$417K Buy
1,297
+313
+32% +$96.1K 0.03% 234
2020
Q3 		$265K Buy
984
+118
+14% +$31.8K 0.02% 256
2020
Q2 		$228K Buy
+866
New +$231K 0.02% 268
2020
Q1 		– Sell
-876
Closed -$265K – 301
2019
Q4 		$265K Sell
876
-69
-7% -$19K 0.02% 275
2019
Q3 		$226K Sell
945
-84
-8% -$23K 0.02% 291
2019
Q2 		$290K Sell
1,029
-39
-4% -$10.7K 0.02% 251
2019
Q1 		$307K Buy
1,068
+112
+12% +$32.4K 0.03% 235
2018
Q4 		$251K Buy
+956
New +$263K 0.02% 259

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Coldstream Capital Management's ELV Position: Q2 2026 in Review

Coldstream Capital Management increased its Elevance Health (ELV) stake by 20% in Q2 2026, buying an estimated $377K and bringing the position to 6,074 shares worth $2.35M. The position accounts for 0.03% of the portfolio, ranked #268.

Coldstream Capital Management first reported a position in ELV in Q4 2018 and has held it in 29 quarters since. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Coldstream Capital Management held 6,074 shares of Elevance Health worth $2.35M as of Q2 2026.
  • Coldstream Capital Management bought 1,017 Elevance Health shares in Q2 2026, an estimated $377K.
  • Elevance Health made up 0.03% of Coldstream Capital Management's portfolio in Q2 2026, its #268 holding.
  • Coldstream Capital Management first reported a position in Elevance Health in Q4 2018 and has held it in 29 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.